v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (3,320) $ (4,601)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2 3
Stock-based compensation 326 1,556
Noncash interest expense 123 10
Warrants received as licensing fee (23)
Change in fair value of equity investment (4)
Change in fair value of derivative liabilities (102)
Other expense related to extension of warrants 412
Loss on extinguishment of derivative liability 288
Common stock payable to consultant 566
Changes in operating assets and liabilities:    
Trade receivable 8 (80)
Other accounts receivable and prepaid expenses 107 (166)
Inventory 12 (9)
Trade payables (46) (7)
Other accounts payable and accrued expenses (19) (161)
Deferred revenue 215
Accrued severance pay, net (20) (35)
Due to related party 50
Net cash used in operating activities (2,073) (2,842)
Cash flows from financing activities:    
Proceeds from issuance of notes payable 42 475
Payments of convertible notes (475)
Proceeds from note issued to related party 200
Payments of note payable to related party (200)
Proceeds from sale of common stock, net 4,223 580
Proceeds from issuance of Preferred Series E stock 3,620
Proceeds from exercise of options 4
Net cash provided by financing activities 4,265 4,204
Net increase in cash, cash equivalents and restricted cash 2,193 1,362
Cash, cash equivalents and restricted cash at beginning of period 1,338 896
Cash, cash equivalents and restricted cash at end of period 3,531 2,258
Supplemental non-cash financing and investing activities:    
Cash paid for interest 5
Cash paid for taxes
Discount on notes payable 123
Issuance of common stock payable 566
Conversion of Series C, D and E Preferred stock into common stock $ 1

Source

PDF HTML
10-Q Filing
ZIP XLS HTML
XBRL